STEP 1
Consultation and Metabolic Assessment
We evaluate your history, symptoms, goals, prior weight-loss response, and current medications.
Our tirzepatide weight loss program is designed for patients who need a more advanced medical approach to appetite regulation, satiety, and body composition change. Treatment includes provider oversight, careful dose titration, and life coach access for every active patient.
Many patients are not just dealing with simple overeating. They are dealing with a deeper metabolic pattern that may include strong hunger signals, cravings, insulin resistance, poor satiety, and increasing difficulty losing weight over time.
For patients with more resistant metabolic dysfunction, tirzepatide may offer a stronger medical weight-loss option.
Supported in All 50 States.
Tirzepatide is a dual-pathway medication that acts through GLP-1 and GIP activity. For the right patient, this may help support stronger appetite control, better satiety, and improved consistency with dietary adherence. At TruLife Metabolix MD, tirzepatide is used as part of a broader care model.
We evaluate your history, symptoms, goals, prior weight-loss response, and current medications.
If tirzepatide is appropriate, we create a dosing and support plan tailored to your needs.
Your response is monitored over time so the plan can be adjusted for effectiveness and tolerability.
Patients also receive life coach access for accountability, routine development, nutritional consistency, and adherence support.
5 quick questions – takes less than 3 minutes.
Our tirzepatide program is offered primarily as a once-weekly injectable treatment. Current FDA-approved weight-loss labeling for tirzepatide is centered on the injectable format.
Supported in All 50 States.
Tirzepatide is started low and increased gradually to reduce GI side effects.
A common injectable progression is:
-2.5 mg once weekly for the first 4 weeks
-Then 5 mg once weekly
If additional effect is needed and the patient is tolerating treatment well, the dose may then increase in 2.5 mg increments after at least 4 weeks on the current dose.
Common maintenance doses are 5 mg, 10 mg, or 15 mg once weekly, and 15 mg once weekly is the maximum recommended dose in current labeling.
The 2.5 mg dose is an initiation dose, not a maintenance dose.
The most common side effects with tirzepatide are usually gastrointestinal, especially during the early weeks or after dose increases.
Because tirzepatide is titrated upward over time, careful follow-up is especially important during the early part of therapy.
We help improve tolerability by:
Many patients find that nausea and related stomach symptoms improve after the body adjusts, especially when dose progression is not rushed.
Supported in All 50 States.
If you are already taking tirzepatide through another provider, you may be able to continue at your current dose rather than restarting from the beginning.
During your initial consultation, we review your recent treatment history and may validate your current prescription before deciding whether continuation at your present dose is appropriate. This can help stable patients maintain continuity during a provider transition.
Supported in All 50 States.
For routine missed tirzepatide doses, current labeling states that if a dose is missed, it should be taken as soon as possible within 4 days (96 hours). If more than 4 days have passed, that dose should be skipped and the next dose taken on the regular schedule.
Supported in All 50 States.
For longer interruptions, the FDA label does not provide the same detailed multi-week restart algorithm used in semaglutide labeling. Because GI side effects can recur after a long break, our clinic generally reassesses patients who have been off tirzepatide for more than 4 weeks, and many will need to restart at or near a lower dose depending on prior tolerance, prior dose, and time off treatment.
If you have been off tirzepatide for more than 4 weeks, your current dose may need to be reassessed, and restarting at or near a lower dose is often recommended to improve tolerability and reduce nausea.
Tirzepatide-based treatment may help support:
At TruLife Metabolix MD, we aim to provide innovative telemedicine solutions for metabolic weight loss and hormone optimization.
This is the starting monthly price for patients who want flexibility. We also offer discounted package pricing on longer plans.
Month-to-Month: Starting at $299/month
We do not treat weight loss as a one-size-fits-all prescription. Your care includes:
Our goal is not just to start treatment. It is to help you stay consistent enough for treatment to work.
We’ve compiled answers to the most common questions our clients ask to help you get a better understanding of how we can assist you.
The common starting dose is 2.5 mg once weekly for 4 weeks, followed by an increase to 5 mg once weekly, with later increases based on tolerability and response.
Tirzepatide is typically taken as a once-weekly injection.
Tirzepatide is titrated gradually to improve tolerability and reduce GI side effects such as nausea, bloating, constipation, diarrhea, and vomiting.
Often, yes. If you can provide a valid current prescription and your recent treatment history can be reviewed during the consultation, continuation at your current dose may be possible.
Your treatment will usually need to be reassessed. Because side effects can return after a long interruption, restarting at or near a lower dose is often considered based on your prior dose, side-effect history, and time off medication. The FDA label clearly addresses a single missed dose within 4 days but does not provide a detailed prolonged-interruption restart sequence.
Yes. Qualified patients may complete consultation, treatment planning, and follow-up through telehealth.
Get a stronger metabolic weight loss strategy with ongoing medical and coaching support. Start with flexible month-to-month tirzepatide treatment, or save more with 3-month and 6-month options.
